Study Summary
This trial is testing a new combination therapy for UC that may be more effective than existing treatments.
- Ulcerative Colitis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: Week 6
Trial Safety
Safety Progress
Side Effects for
Trial Design
1 Treatment Group
FMT and vedolizumab
1 of 1
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Fecal microbiota transplantation · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this clinical trial a pioneer endeavor in its field?
"To date, 23 clinical trials for Fecal microbiota transplantation are in progress across 312 cities and 42 countries. An inaugural experiment was initiated by Takeda back in 2015 with 260 participants to reach the final phase of drug approval; since then 40 such studies have been completed." - Anonymous Online Contributor
How many participants are the maximum that can join this trial?
"Affirmative. According to clinicaltrials.gov, the search for participants is currently ongoing and has been since May 1st 2021. The trial was recently updated on August 23rd 2022 and 10 people are sought from a single site." - Anonymous Online Contributor
Is this examination currently recruiting participants?
"Clinicaltrials.gov indicates that this trial is actively seeking subjects, with the study first announced on May 1st 2021 and revised as recenty as August 23rd 2022." - Anonymous Online Contributor
Has the FDA authorized Fecal microbiota transplantation for medical use?
"Fecal microbiota [transplant](https://www.withpower.com/clinical-trials/transplant)ation is approved for medical use and has been sufficiently studied, so it was assigned a safety rating of 3." - Anonymous Online Contributor